Jack Cuzick, PhD


Authored Items

Tamoxifen or Anastrozole for DCIS? Age and Symptom Profiles Matter

March 2016, Vol. 5, No. 2 - San Antonio Breast Cancer Symposium

Tamoxifen and anastrozole are similarly effective in preventing breast cancer recurrence in postmenopausal women with ductal carcinoma in situ (DCIS). The choice depends on patient preferences, side effect profiles, age, and other patient factors, according to separate studies presented at the 2015 San Antonio Breast Cancer Symposium.In the large, placebo-controlled [ Read More ]

Sign me up!